Trademark: DALIRESP
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for DALIRESP
We do not have any records of a proof of use for DALIRESP at this moment.
Possible trademark infringements of DALIRESP
Basic Information about DALIRESP
- Serial Number
- 85265098
- Filing Date
- 11 Mar 2011
- Registration Number
- 4055617
- Registration Date
- 15 Nov 2011
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of DALIRESP on the blockchain with WikiTrademarks.io.
- First use of DALIRESP anywhere
- DALIRESP was first used on 23 May 2011 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns DALIRESP?
1. ASTRAZENECA AB Södertälje
2. TAKEDA GMBH KONSTANZ
3. TAKEDA GMBH 78467 KONSTANZ
4. Nycomed GmbH 78467 Konstanz
5. Nycomed GmbH 78467 Konstanz
6. Nycomed GmbH 78467 Konstanz
Correspondent
- Cara M. Kearney
- AstraZeneca Pharmaceuticals LP
- 1800 Concord Pike, A2C
- Wilmington DE 19850-5437
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io